XML 82 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)
 12 Months Ended
Jul. 21, 2022
USD ($)
Dec. 31, 2021
segment
Dec. 31, 2023
USD ($)
segment
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2013
USD ($)
Nov. 19, 2021
USD ($)
Goodwill [Line Items]                
Number of operating segments | segment     2          
Number of segments | segment   1 2          
Goodwill, impairment loss     $ 0 $ 0 $ 0      
Goodwill     28,221,000 28,221,000        
Increase (decrease) in definite-lived intangible assets     16,400,000          
Finite-lived intangible gross carrying amount     497,332,000 480,915,000        
Intangible assets acquired     9,600,000          
Amortization of intangible assets     52,300,000 49,500,000 41,800,000      
Intangible asset impairment charge     $ 0 112,000 2,374,000      
Minimum                
Goodwill [Line Items]                
Amortization period     7 years          
Maximum                
Goodwill [Line Items]                
Amortization period     10 years          
Oakrum Pharma                
Goodwill [Line Items]                
Amortization period 7 years              
Intangible asset impairment charge     $ 0          
Reclassification of Assets on Completion of Project and Launch of Related Products | In process research and development                
Goodwill [Line Items]                
Finite-lived intangible gross carrying amount     (6,800,000) (20,300,000)        
Acquired ANDA intangible assets                
Goodwill [Line Items]                
Finite-lived intangible gross carrying amount     209,780,000 195,862,000        
Intangible asset impairment charge     0 100,000        
Acquired ANDA intangible assets | Slayback Pharma Limited Liability Company and Akorn Holding Company                
Goodwill [Line Items]                
Intangible assets acquired     7,100,000          
Acquired ANDA intangible assets | Oakrum Pharma                
Goodwill [Line Items]                
Amortization period 7 years              
Finite-lived intangible gross carrying amount $ 7,200,000              
Intangible assets acquired $ 7,200,000              
Acquired ANDA intangible assets | Reclassification of Assets on Completion of Project and Launch of Related Products                
Goodwill [Line Items]                
Finite-lived intangible gross carrying amount     6,800,000 $ 20,300,000        
Product Rights | Alvogen Inc                
Goodwill [Line Items]                
Intangible assets acquired     $ 2,000,000          
BioSante Pharmaceuticals                
Goodwill [Line Items]                
Acquisition of goodwill             $ 1,800,000  
WellSpring                
Goodwill [Line Items]                
Acquisition of goodwill           $ 1,700,000    
Novitium                
Goodwill [Line Items]                
Acquisition of goodwill         $ 24,600,000      
Goodwill               $ 24,600,000